본문 바로가기

Signed a contract to attract investment in DNA vaccine R&D and manufacturing facilities
  • Date Created : 2021-08-24
  • Number of Views : 120
(210824)DNA 백신 연구개발 투자 계약 체결(9234)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9233)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9232)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9231)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9230)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9229)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9228)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9234)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9233)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9232)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9231)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9230)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9229)-3000px
(210824)DNA 백신 연구개발 투자 계약 체결(9228)-3000px
On August 24, 2021 (Tuesday), IFEZ and SL POGEN signed a land sale contract for the establishment of DNA vaccine R&D and manufacturing facilities in Songdo International City Advanced Industrial Cluster (B). The manufacturing and research facilities will be located in the high-tech industrial cluster (B) (Songdo-dong 218-8) of Songdo International City District 5 and will have a four-story total floor area of 12,200 square meters. Construction began in the first half of 2022 and is under construction with a goal of completing construction in 2023. The project will cost 48 billion won, and foreign investor Kalbe Farma (Indonesia) will invest 11 billion won (10 million dollars). * Vaccines made from DNA. Artificially reproduced genes such as pathogens and viruses. Injects this into the muscles to trigger an immune response to the pathogen or virus.